![Piet Wigerinck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Piet Wigerinck
Direktor/Vorstandsmitglied bei IPSEN
Vermögen: 89 028 $ am 31.05.2024
Aktive Positionen von Piet Wigerinck
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IPSEN | Direktor/Vorstandsmitglied | 01.05.2018 | - |
Independent Dir/Board Member | 01.05.2018 | - | |
University Hospital Antwerp
![]() University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium. | Direktor/Vorstandsmitglied | - | - |
miDIAGNOSTICS NV
![]() miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - | |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - | |
Symeres BV
![]() Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Piet Wigerinck
Ehemalige bekannte Positionen von Piet Wigerinck
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GALAPAGOS NV | Technik-/Wissenschafts-/F&E-Leiter | 19.04.2012 | 31.12.2021 |
Corporate Officer/Principal | 01.04.2008 | 19.04.2012 | |
UZA Foundation | Direktor/Vorstandsmitglied | - | - |
Xinvento BV
![]() Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Gründer | - | - |
Tibotec-Virco Comm Va | Corporate Officer/Principal | - | - |
░░░░ ░░░░░░░░░ ░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Piet Wigerinck
Katholieke Universiteit Leuven | Doctorate Degree |
Statistik
International
Belgien | 7 |
Niederlande | 3 |
Frankreich | 2 |
Operativ
Director/Board Member | 6 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 3 |
Sektoral
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
IPSEN | Health Technology |
GALAPAGOS NV | Health Technology |
Private Unternehmen | 8 |
---|---|
University Hospital Antwerp
![]() University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium. | Health Services |
miDIAGNOSTICS NV
![]() miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Commercial Services |
Drug Discovery & Development Solutions Ltd.
![]() Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Drug Discovery & Development Solutions Ltd. engages in the provision of financial services. The company is headquartered in Singapore. | Commercial Services |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Health Technology |
Symeres BV
![]() Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Health Technology |
Tibotec-Virco Comm Va | |
Xinvento BV
![]() Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Health Technology |
UZA Foundation |
- Börse
- Insiders
- Piet Wigerinck
- Erfahrung